JAZZ: COZADD BRUCE C discloses a sale
By AlphaYouPublished Form 4
COZADD BRUCE C
Reporting filer
COZADD BRUCE C reported Sale in Jazz Pharmaceuticals plc: 6000 units of Ordinary Shares, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | COZADD BRUCE C | 2026-10-01 | S | Sale | 6000 | 230.33 | 345,875 | 4 days | Filed terms
|
Ordinary Shares
- Owner
- COZADD BRUCE C
- Date
- 2026-10-01
- Code
- S
- Action
- Sale
- Quantity
- 6000
- Price
- 230.33
- Following holdings
- 345,875
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Ordinary Shares
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 6000
- transaction Price Per Share: 230.33
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 345875
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- COZADD BRUCE C: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.
Original sources
Prepared automatically from public filing data. Report a correction.